CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
Abstract Human cancers harbor substantial genetic, epigenetic, and transcriptional changes, only some of which drive oncogenesis at certain times during cancer evolution. Identifying the cancer-driver alterations amongst the vast swathes of “passenger” changes still remains a major challenge. Transp...
Main Authors: | Imran Noorani, Allan Bradley, Jorge de la Rosa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Genome Biology |
Online Access: | http://link.springer.com/article/10.1186/s13059-020-02118-9 |
Similar Items
-
Dual modes of CRISPR-associated transposon homing
by: Saito, Makoto, et al.
Published: (2022) -
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice
by: Julia Weber, et al.
Published: (2019-03-01) -
Bacterial Genome Engineering with CRISPR RNA-Guided Transposons
by: Vo, Phuc Hong
Published: (2022) -
Structure and Function of a Transposon-Encoded CRISPR-Cas System
by: Halpin-Healy, Tyler Sheehan
Published: (2021) -
Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo
by: Richard T. O’Neil, et al.
Published: (2018-04-01)